Pear Therapeutics, Inc. (PEAR) |
|
0.2646 -0.071 (-21.04%)
|
03-22 15:02 |
|
Open: |
0.3 |
Pre. Close: |
0.3351 |
|
High:
|
0.3117 |
Low:
|
0.2645 |
|
Volume:
|
1,433,860 |
Market Cap:
|
56(M) |
|
|
|
Technical analysis |
as of: 2023-03-22 2:50:07 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 0.94 One year: 1.37 |
| Support: |
Support1: 0.2 Support2: 0.16 |
| Resistance: |
Resistance1: 0.8 Resistance2: 1.17 |
| Pivot: |
0.64  |
| Moving Average: |
MA(5): 0.36 MA(20): 0.73
MA(100): 1.43 MA(250): 2.24 |
| MACD: |
MACD(12,26): -0.3 Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 8.7 %D(3): 9.3 |
| RSI: |
RSI(14): 23.2 |
| 52-week: |
High: 6.73 Low: 0.2 |
| Average Vol(K): |
3-Month: 597 (K) 10-Days: 2,547 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PEAR ] has closed above bottom band by 13.8%. Bollinger Bands are 64.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.48 - 0.48 |
0.48 - 0.49 |
|
Low:
|
0.25 - 0.25 |
0.25 - 0.25 |
|
Close:
|
0.33 - 0.34 |
0.34 - 0.34 |
|
Company Description |
|
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts. |
Headline News |
Wed, 22 Mar 2023
Pear Therapeutics Inc (PEAR) Stock Falls -50.00% This Week: Is It a Good Pick? - InvestorsObserver
Wed, 22 Mar 2023
Why GameStop Shares Are Trading Higher By Around 44%; Here ... - Investing.com UK
Tue, 21 Mar 2023
Why Is Pear Therapeutics (PEAR) Stock Up 21% Today? - InvestorPlace
Mon, 20 Mar 2023
U.S. stocks higher at close of trade; Dow Jones Industrial Average ... - Investing.com
Mon, 20 Mar 2023
PEAR stock extends selloff as downgrades follow strategic shake-up ... - Seeking Alpha
Sun, 19 Mar 2023
Pear Therapeutics' Cuts Are Not Enough; 'Strategic Alternatives' Among Next Steps - MedCity News
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Health Information Services |
| Shares Out. |
0 (M) |
| Shares Float |
140 (M) |
|
% Held by Insiders
|
3.653e+007 (%) |
|
% Held by Institutions
|
16.8 (%) |
|
Shares Short
|
1,660 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-1.2342e+008 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
-265.3 |
|
Operating Margin (%)
|
-1 |
|
Return on Assets (ttm)
|
109.6 |
|
Return on Equity (ttm)
|
-76.7 |
|
Qtrly Rev. Growth
|
1.145e+007 |
|
Gross Profit (p.s.)
|
0.05 |
|
Sales Per Share
|
0.02 |
|
EBITDA (p.s.)
|
-0.78 |
|
Qtrly Earnings Growth
|
-0.2 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-129 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
12.97 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
1.7e+006 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
